Regenerative implant producer OssDsign, based on research at Karolinska University Hospital and Uppsala University, hopes to list on the Nasdaq First North and raise $15.8m.

OpenTable will offer Venga's customer analytics software to its restaurant clients following the acquisition, which will allow Big Red Ventures to exit.

Meat substitute developer Beyond Meat, which has received backing from two corporate venturers, went public.

Hannover Medical School chip cytometry spinout Zelkraftwerk has been bought by Canopy Biosciences, providing an exit for tech transfer company Ascenion.

The Tencent-backed cosmetic procedure-booking and social media platform floated at the top of its range in a US offering that came after more than $229m of funding.

Pharmstandard, Lung Biotechnology and Posco celebrated exits as the organ transportation system developer went public in a $91m offering.

Exosome therapeutics developer Codiak BioSciences, exploiting technology developed by researchers at the universities of Gothenburg and Texas, is eyeing up to $86.3m in an IPO.

General Mills-backed meat substitute developer Beyond Meat priced its shares at the top of an expanded range, but Tyson Foods had already sold its stake.

Alexandria Real Estate Equities-backed exosome therapeutics developer Codiak BioSciences is eyeing up to $86.3m in a forthcoming IPO.

Telus Ventures is set to exit healthcare data management software producer Get Real Health in an $11m purchase by CPSI, six years after it invested.